(RTTNews) - Novartis (NVS) unveiled late-breaking Phase 3 RemIND trial data at the EAACI Congress, highlighting the potential of Rhapsido (remibrutinib...
IDDI Competitors or Alternatives
IDDI's top competitors include PPD, CD3 and IQVIA.
Looking for similar companies to IDDI?
Similar Companies
Companies in Louvain-la-Neuve with revenue in $5.0-25M range
See 11 companies
Professional Services companies in Walloon BrabantSee 35 companies
Companies in Louvain-la-Neuve with employees in 25-100 rangeSee 12 companies
Professional Services companies in Louvain-la-NeuveSee 36 companies
Companies in Walloon Brabant with employees in 25-100 rangeSee 55 companies
Companies in Walloon Brabant with revenue in $5.0-25M rangeSee 59 companies
Scientific R&D Services companies with employees in 25-100 rangeSee 197 companies
Scientific R&D Services companies with revenue in $5.0-25M rangeSee 320 companies
Scientific R&D Services companies in BelgiumSee 330 companies
Trending News for IDDI and IDDI's Competitors
(RTTNews) - AstraZeneca's (AZN,AZN.L,ZEG.DE,AZN.ST) Truqap (capivasertib), in combination with abiraterone and prednisone, has been approved in the US ...
Amgen challenges FDA's proposed Tavneos withdrawal, seeks hearing, and cites independent Duke review of trial data.read more...
BASEL (dpa-AFX) - Novartis AG (NVS) on Thursday presented data from the Phase III RemIND trial at the European Academy of Allergy and Clinical Immunolo...
Drug major Novartis announced that the biomarker cohort of the FORTITUDE phase I/II study of del─brax met its primary and key secondary endpoints, with...
FDA concerns about Amgen's Tavneos were sparked by securities fraud litigation against ChemoCentryx, the company that originally developed the rare dis...
After the FDA flagged patient deaths linked to Amgen's rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independ...
LONDON (dpa-AFX) - AstraZeneca's (AZN,AZN.L,ZEG.DE,AZN.ST) Truqap (capivasertib), in combination with abiraterone and prednisone, has been approved in ...
AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for ...
- Amgen's IMDYLLTRA shows 40% reduced mortality in Phase 3 trials, earning FDA full approval and European marketing authorization as a Category 1 NCCN ...
Frequently Asked Questions about IDDI
Who are IDDI's top competitors?
IDDI's top 3 competitors are PPD, CD3, IQVIA.Who is similar to IDDI?
PPD is the most similar to IDDI. CD3 and IQVIA are also similar to IDDI.
Are IDDI and PPD competitors?
Yes, PPD is one of IDDI’s top competitors.